Diagnosis of Smear negative pulmonary TB in high HIV settings: RESEARCH PRIORITIES Haileyesus Getahun, Stop TB, WHO. Expert consultation on TB/HIV research.

Slides:



Advertisements
Similar presentations
Diagnosis of AFB Smear- Negative Pulmonary TB in HIV- Infected Persons Richard OBrien Foundation for Innovative New Diagnostics (FIND)
Advertisements

Nursing Diagnosis: Definition
Radiographer Reporting Presented by Chan Tsz Chun d Ng Kwan Ho d Wong Kin Long, Gulliver d.
Evaluation Questions Note: If not used for testing purposes, evaluation questions may be used in slide format inserted within or at the end of each module.
ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
Your name Institution/organization Meeting Date. Introduction.
Clinical Presentation and Diagnosis of Tuberculosis Your name Institution/organization Meeting Date International Standards 1-5.
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
Opportunities. Shift in Perspective for Infectious Disease Control (Porter et al 1999 Health Policy and Planning 14: ) From: Disease specificity.
Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
` COMPARATIVE ACCURACY OF CARTRIDGE BASED NUCLEIC ACID AMPLIFICATION TEST AND SPUTUM MICROSCOPY FOR DIAGNOSIS OF PULMONARY TUBERCULOSIS IN HIV POSITIVE.
Exploring Synergies Health Systems and Sustainability TB/HIV collaboration Alasdair Reid UNAIDS Pretoria International Multistakeholder Consultation on.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
Improving diagnosis TB laboratory strengthening.
Country Update: Tuberculosis in Thailand
Dr R Ramachandran 5 th Joint International Monitoring Mission to Review NTP Thailand 5th JMM Thailand.
Of South Africa DOTS WORKS VWSA WORKPLACE PROGRAM.
Key elements to develop a national strategic plan for TB control Malgosia Grzemska Stop TB Department WHO, Geneva, Switzerland EURO/TBTEAM Regional Workshop.
Expert consultation on TB/HIV research priorities, February 2005 Mesdames et messieurs, soyez les bienvenus On behalf of the organizing committee.
Institute for Public Health, Medical Decision Making and Health Technology Assessment 1 Results of the PanEuropean Hepatitis C Project 3 rd Paris Hepatitis.
Improving direct microscopy by overnight bleach sedimentation: a simple tool for peripheral Health Centres Maryline Bonnet 1, Laramie Gagnidze 1, Willie.
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
World Health Organization TB Case Definitions
Living with HIV, Dying of TB Intensified TB case finding among people living with HIV Adapted from presentation by Colleen Daniels TB/HIV Advocacy Stop.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
KEY CHANGES IN THE NEW NTBLCP GUIDELINES
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Diagnosis of TB.
Moving forward in the diagnosis of infectious diseases in developing countries: a focus on malaria Forum organized by Fondation Mérieux & the Roll Back.
Zero TB deaths among PLHIV: what are the gaps and what is missing? Haileyesus Getahun Stop TB Department World Health Organisation, Geneva. Reaching Zero.
Unit 5: IPT Isoniazid TB Preventive Therapy
Module 10: Understanding Laboratory Data *Image courtesy of: World Lung Foundation.
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
Plans for Diagnosis and Management of Acute Pyelonephritis.
Xpert in the diagnostic algorithm of pulmonary TB in adult patients who are neither high risk for HIV, nor high risk for MDR-TB Preparations for the global.
Characteristics and Outcomes of a Population of Tuberculosis Inpatients in Lilongwe, Malawi Mina Hosseinipour, MD, MPH Clinical Director UNC Project Lilongwe,
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
DEPARTMENT OF HEALTH DOTS Program for TB (Tuberculosis Directly Observed Short-course)
Tuberculosis Research of INA-RESPOND on Drug-resistant
TB and Poverty in The Global Plan to Stop TB Valerie Diaz, Sarah England, Knut Lönnroth, Giorgio Roscigno Stop TB Partnership Stop TB Department,
Project Goals  Support the National Tb Program (NTP)  Developed National Guidelines for prevention and control of Tb  Developed guidelines for treating.
Treatment of Tuberculosis: New Case Case Studies Module 7A2 – March 2010.
Smear negative TB and HIV: urgent research priorities to inform a rolling global policy Haileyesus Getahun, MD, MPH, PhD Stop TB Department WHO/HQ.
Implementation of Thin Layer Agar for Mycobacterium culture in rural Kenya Médecins Sans Frontières.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
International Health Policy Program -Thailand Policy decision on multi drug resistant(MDR), extreme drug resistant(XDR) tuberculosis screening: How it.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
High cost of Xpert MTB/RIF ® testing per tuberculosis case diagnosed at Partners in Hope Medical Center, a public private HIV care clinic in Lilongwe,
Haileyesus Getahun Stop TB Department WHO Re-conceptualizing ICF and IPT: global progress to date 14 th Core Group Meeting of the TB/HIV Working Group,
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Module 2 TB Disease Transmission & Prevention. Pulmonary Tuberculosis Extra -Pulmonary TB an infectious disease caused by a microorganism called Mycobacterium.
Screening for TB among risk groups in Cambodia Dr. Mao Tan Eang, NTP Director National Center for TB and Leprosy Control, Cambodia TAG Meeting, 9-12 December.
TB Control Measures: From development and endorsement to adoption and implementation Léopold Blanc TBS Stop TB department WHO Christy Garcia University.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Early TB case detection in pre-trial detention centers (SIZOs) and prison colonies in Ukraine 46 th Union World Conference on Lung Health Cape Town, South.
GLOBAL TB PROGRAMME Systematic screening for active TB – operational manual and tool to help prioritization Wolfheze 2015 Knut Lönnroth, Global TB Programme.
Roundtable. Detection and treatment of TB Andrew Black.
Optimization of Sputum Smear for Detection of TB: A Prospective Blinded Evaluation Joy Sarojini Michael, Kalaiselvan S, Peter Daley, Lois Armstrong, Shalini.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
ConsultASK Management Consulting LLC H-1121 Budapest, Konkoly-Thege M. út Tel.: FAX: Automated TB diagnosis Robot.
New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.
William Burman Denver Public Health Tuberculosis Trials Consortium
This is an archived document.
PROGRESS IN GLOBAL TB CONTROL
Presentation 10 Analysing results and defining cases
DOTS EXPANSION AND BEYOND DOTS World Health Organization
Presentation transcript:

Diagnosis of Smear negative pulmonary TB in high HIV settings: RESEARCH PRIORITIES Haileyesus Getahun, Stop TB, WHO. Expert consultation on TB/HIV research priorities,14-15 February 2005, Geneva, Switzerland

Smear negative pulmonary TB At least three negative sputum specimens for AFB AND Radiographic abnormalities consistent with active TB AND No response to a course of broad spectrum antibiotics AND Clinician decision to treat with a full course of TB drugs

Differential diagnoses in PLWHA Bacterial pneumonia Kaposis sarcoma Pneumocystis carinii pneumonia Cryptococossis Nocardiosis Penicilliosis Melioidosis Histoplasmosis Etc..

Magnitude of SN- pulmonary TB in PLWHA Significant increase in incidence in HIV+ Inferior treatment outcomes than HIV- In published data SN- in PLWHA ranges from 24-61% ( 28% in 7763 patients) However, –Institution based (poor health coverage) studies –Biased towards smear positives –In autopsy TB causes 14-54% of PWA deaths

Global TB data end of 2003

Global TB data, end 2003

Proportion smear negative of all pulmonary cases with HIV prevalence in selected sub-Sahara African countries, 2003.

SN- pulmonary TB in NTP Diagnosis of smear negative pulmonary TB in resource constrained settings is difficult. Less attention by NTP to document treatment outcome of SN- cases. SN- is an important component of TB that needs more urgent attention by NTP

WHO-Diagnostic Algorithm

Diagnostic algorithm Algorithm adapted from WHO Key parameters include –AFB sputum smear examinations –Diagnostic antibiotic trial (s) –CXR –Medical officer's judgement –Group discussion of the case (peer review) Best scenario assumption= days Few studies address delay in diagnosis among PLWHA (Thailand and Zimbabwe) Other suggested clinical predictors include weight loss and anaemia.

Sputum smear microscopy If sensitivity improved-it is more valuable tool Positive threshold –Reported as when >10 AFB/100 HPF –< 10 AFB/HPF reported in exact numbers – Scanty:" competent authority" to decide (c.f) Fluorescence microscopy –Increase ZN yield (15% and 18%) –15X more field scanned in the same period than ZN –Reduce time needed (4 mt vs 10 mts) –Cost effective- $40 (on 2 sputa) vs $57(ZN 3 sputa) –Limitations: Economic, require electricity, naturally fluorescent particles

Bleach method Most widely studied method Centrifugation and sedimentation

Bleach method 95% CI of relative improvement of sensitivity

Bleach method Most widely studied method Centrifugation and sedimentation Used in 3 countries under routine NTP Additional processing time is the limitation Sensitivity 3850% among PLWHA Most studies in hospital or research settings Technique is not standardised.

Sputum Culture 5-10 x more expensive Selective recommendation (? Underutilised) Sophisticated facilities and expertise Contamination (1-4%) Takes 6-8 weeks MGIT –8-20 vs days –The same facilities –Expensive –More contamination

Intensified TB case finding Early detection of cases through intensive case detection Practical Approach to Lung Health (PAL) improves efficiency of resp services and improves TB case detection Involvement of community members is very important

Conclusion Expedite the search for new and rapid tools However, in the meantime Research should be focused –To immediately inform changes in policy and practice (e.g. rapid and effective diagnostic algorithm) –To hasten the expansion and utility of existing diagnostic methods (e.g. bleach, culture facilities in peripheral settings) –To inform the development of appropriate technologies for resource constrained settings (e.g. culture facility using solar energy)